We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Equiniti Group Plc | LSE:EQN | London | Ordinary Share | GB00BYWWHR75 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 179.80 | 179.80 | 180.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/11/2017 12:21 | Berenberg initiates coverage with 'buy' and tp 345p | philanderer | |
24/11/2017 08:59 | The next big thing should be the first report on how they have digested the Wells Fargo business. Like many, I always read about "not buying predators" because they seem to always mess up the integration phase. Hopefully Equiniti looks like a different breed from that of an over leveraged tech company going on a buying spree of other tech companies. Depending on how the tea-leaves are read, 320p by Christmas is a welcome possibility. | vacendak | |
23/11/2017 18:00 | The share price has moved up nicely today on the back of the positive TU. It looks like the overhang has been cleared. If this is the case then the share price could move up nicely in the next couple of weeks, maybe testing £3.20. But I am not getting too excited this is the third time I have called this only for the institutional selling to continue. | mr doughnut1 | |
22/11/2017 10:34 | No problem. | vacendak | |
22/11/2017 09:56 | That's the one, well done. | dondee | |
21/11/2017 22:43 | Good write up in the Sunday Telegraph business pages on 19/11/17 re EQN snapping up Wells Fargo services arm etc. | dondee | |
17/11/2017 21:00 | I am hoping for an in-line statement on Tuesady. There will be an obvious focus on organic growth, which showed a 0.6 percent decline in the June figs. The managed insitutional selling may have kept the share price artificially high following the rights issue. Trading volumes are only now returning to normal PI levels. GLA | mr doughnut1 | |
31/10/2017 21:29 | Next trading update on 21st Nov. Share price has been sticky around £3.00 for a couple of months now which I think is a positive sign. The discounted rights issue had a 97.4% take up, producing in excess of 62.5m shares. Anyone wanting to make a quick profit has now done so and the insitutional horse trading is coming to an end, Blackrock adding today. Would be interested to hear other investors views in the run up th the 21st Regards. | mr doughnut1 | |
06/10/2017 21:12 | Podcast on investors chronicle website - board room talk with Mark Robinson, interviews Guy Wakeley. Worth a listen. The Wells Fargo takeover gives EQN access to a US market where there are 18,000 companies that issue shares compared to 2500 in UK. There are strong synergies between the two companies that will enable EQN to transfer technology platforms directly to US, that still appears to be largely paper based. Interestingly at the end of interview GW flags up building up on-line share dealing services as a real growth area integrating them into people's pension services as the process of deregulation continues to evolve. Have taken up rights | mr doughnut1 | |
29/9/2017 09:10 | My previous post about the new chairman was with my tongue firmly in cheek. I should have put a :) Thanks for the reminder about the dealing in rights, that must explain it indeed. [edit] Still down but not as bad as earlier this morning. | vacendak | |
29/9/2017 08:52 | Sounds pretty reasonable to me: "Yea has been chairman of pub operator Greene King PLC since May and is a senior independent director at Computacenter PLC. He is a non-executive director of Aberdeen Asian Smaller Companies Investment Trust PLC and Marshall of Cambridge (Holdings) Ltd, as well as an independent director and trustee of the Francis Crick Institute." | jgoold | |
29/9/2017 08:47 | Dealings in Rights, nil paid, 8 a.m. on 29 September commence on the London Stock 2017 Exchange The Ex Rights Date 29 September 2017 | darlocst | |
29/9/2017 08:28 | Sharp drop at the opening today. Maybe someone does not like the new chairman: | vacendak | |
12/9/2017 12:37 | Latest RNS on the Wells Fargo story: Quick summary: "3 for 14 at 190p per share" / Fully underwritten. At this price, I am not sure we will be offered to bid for much more than our entitlement. [edit] And we got our 300p before Christmas! :) | vacendak | |
10/9/2017 20:10 | More institutional buying with the completion of a 14.2m purchase by Nortrust nominees ltd. This comes at a time when a lot of insitutuons seem to be going into cash. Very reasonable under 3.20, IMO | mr doughnut1 | |
07/9/2017 18:13 | A lot going on this week Today Liberum Capital issued a buy rating with a target of 3.47. This follows Goldmans buy rating on the 1st with a target of 3.20. The share has been ticking up nicely in the last couple of days on relatively normal volumes 300,000+ per day then there were 2 large buys this morning at 2.91 of 1.66m and 0.72m shares. Started to thing we had a breakout only dampered bu a sell of 1.87m this afternoon at 2.91p. Not as hot as IQE but things might be warming up again | mr doughnut1 | |
05/9/2017 15:53 | Equiniti mentioned in the FT. "Wealth managers begin to outsource in drive to cut costs" [Relevant bit in case the article goes to Premium access] Mark Taylor, chief customer officer at Equiniti, said regulatory changes were driving new business. “Many wealth managers and private banks have their hands full looking to implement [the regulatory] changes,” he said. “It is so much easier to outsource those functions that are not necessarily core to the operation.” Again, since most of us seem to be reading the ARs, this plays to the company's strength: Decent platform, newly developed, reliable, etc. | vacendak | |
01/8/2017 08:48 | Been off line for a few days so only just read interim's Would agree with all the analysis by vacendak and Lurki0 the market was expecting more debt reduction and better figs on organic growth hence the share price fall. Going forward I still think it is a good investment. We perhaps expected too much from the interim's because when the share price is on a roll everyone's expectations are moved up a notch. However the slight decline in organic growth proves just how tough the market place is at the moment. The U.K. Economy is definitely at a tipping point at the moment with consumer confidence definitely ebbing away. The purchase of 40,000 shares by incoming director on the 31st may steady the share price short term but we will have to see where the support price kicks in at. | mr doughnut1 | |
31/7/2017 14:23 | Sold half after the results but the US acquisition still makes this very interesting. | jgoold | |
28/7/2017 09:49 | I am more focused on the debt reduction, I know money is cheap, let's borrow yada-yada... but I am old-fashioned. It is going down again, however not by as much as expected. The leverage ratio is now 2.8x and was 2.9x in June 2016. The debt load was a concern at IPO time, they seem to be working on it (they always say so anyway); but with the Wells Fargo development it is likely going to be harder still to lower it by the next report date. The share price is now down by 8.0%. Needless to say that the momentum for 300p by Christmas is indeed gone! :( Still, this could be only a necessary correction. Not selling today in any case. The market seems to be down today, that does not excuse the EQN sharp drop, but there is some negative background noise nonetheless. | vacendak | |
28/7/2017 09:07 | Disappointing. What the market doesn't like,understandably, is when a company sells itself on generating organic growth and then shows a negative number. I must say I was hoping for rather more momentum on revenue than they've reported. Buyers seem willing to buy at 268-270, but it will be a bit bumpy through to the close. | lurki0 | |
28/7/2017 08:33 | The results are out, but the share price is getting knocked down by 6.3% at the moment. Every indicator seems to be green except for "a slight decline in organic growth", as quoted. The other negative being: "Revenue from interest was 19.0% lower than the prior period due to the impact of lower interest on average client cash balances of £1.7bn (H1 2016: £1.7bn)." Interim divi of 1.75p (up 6.7% from last time), ex-div date September 15th, to be paid on October 26th. | vacendak | |
28/7/2017 06:53 | I agree, haven't had time to look at trades for yesterday, but any time there is late buying prior to interim's is an extremely positive sign. Hope you managed a top up Lurki0. | mr doughnut1 | |
27/7/2017 17:20 | Judging by the last two hours of trading it would appear I'm not the only one who has high expectations of tomorrow's results. | lurki0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions